spacer
The Healthcare Sales & Marketing Network celebrates 25 years serving the medical sales & marketing community.Connecting Medical Independent Sales Reps and Distributors with Manufacturers and New Product LinesConnecting Medical Independent Sales Reps and Distributors with Manufacturers and New Product Lines

Healthcare Industry News:  VIASYS Healthcare 

Devices FDA

 News Release - January 8, 2007

VIASYS Receives FDA Approval to Market Its PulmoLife(TM) Spirometry Screener

CONSHOHOCKEN, Pa.--(HSMN NewsFeed)--VIASYS Respiratory Care Inc., a subsidiary of VIASYS Healthcare Inc. (NYSE:VAS ) received approval to market its PulmoLife spirometry screener by the United States Food and Drug Administration. The PulmoLife screener is a new device designed for quick and easy assessment of lung disease associated with airflow obstruction known as Chronic Obstructive Pulmonary Disease (COPD).

According to the Center for Disease Control, COPD is currently the fourth leading cause of death in the U.S. and is projected to be the third leading cause of death by the year 2020. There are an estimated 16 million people in the United States diagnosed with COPD and an additional 14 million undiagnosed. Smokers are at greater risk of developing COPD, but breathing in other kinds of lung irritants, like pollution, dust, or chemicals, over a long period of time may also cause or contribute to COPD.

The PulmoLife device uses spirometry to measure lung function. According to the National Institutes of Health, "Spirometry is the most sensitive and commonly used test of lung functions. It can detect COPD long before you have significant symptoms." Early detection of decreased lung function by the PulmoLife device may help a smoker realize the damage smoking can cause and encourage them to seek smoking cessation advice as well as appropriate medical treatment.

ABOUT VIASYS Healthcare INC.

VIASYS Healthcare Inc. is a global, research-based medical technology company focused on respiratory, neurology, medical disposable and orthopedic products. VIASYS products are marketed under well-recognized trademarks including, among others, AVEA®, BEAR®, BIRD®, CORFLO®, CORPAK®, CORTRAK®, EME®, GRASON-STADLER®, JAEGER(TM), LYRA®, MEDELEC®, MICROGAS®, NAVIGATOR®, NICOLET®, NicoletOne(TM), PULMONETIC(TM), SENSORMEDICS®, TECA®, TECOMET(TM), VELA® and VMAX®. VIASYS is headquartered in Conshohocken, PA, and its businesses are conducted through its Respiratory Care, NeuroCare, MedSystems and Orthopedics business units. More information can be found at http://www.viasyshealthcare.com.

Source: VIASYS Healthcare

Issuer of this News Release is solely responsible for its content.
Please address inquiries directly to the issuing company.

Search: VIASYS Healthcare 
Search: PulmoLife 
Search: spirometry 
Healthcare Industry NewsFeed  


FindReps - Find Great Medical Independent Sales Reps without recruiter fees.
FindReps - available on the Apple App Store for iPhone and iPad.